Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis
Introduction Systemic inflammation is associated with prognosis in solid tumors. The
neutrophil-to-lymphocyte ratio (NLR) is a marker for the general immune response to various …
neutrophil-to-lymphocyte ratio (NLR) is a marker for the general immune response to various …
Prognostic utility of baseline neutrophil-tolymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis.
DB Sacdalan, JA Lucero… - OncoTargets & …, 2018 - search.ebscohost.com
Introduction: Systemic inflammation is associated with prognosis in solid tumors. The
neutrophil-to-lymphocyte ratio (NLR) is a marker for the general immune response to various …
neutrophil-to-lymphocyte ratio (NLR) is a marker for the general immune response to various …
[HTML][HTML] Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis
DB Sacdalan, JA Lucero, DL Sacdalan - OncoTargets and therapy, 2018 - ncbi.nlm.nih.gov
Methods We performed a meta-analysis of published articles on the utility of baseline NLR in
predicting outcomes in patients treated with immune checkpoint inhibitors (ICIs) using …
predicting outcomes in patients treated with immune checkpoint inhibitors (ICIs) using …
[引用][C] Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis
DB Sacdalan, JA Lucero, D Sacdalan - OncoTargets and Therapy, 2018 - cir.nii.ac.jp
Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune
checkpoint inhibitors: a review and meta-analysis | CiNii Research CiNii 国立情報学研究所 学術 …
checkpoint inhibitors: a review and meta-analysis | CiNii Research CiNii 国立情報学研究所 学術 …
Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis.
DB Sacdalan, JA Lucero, DL Sacdalan - Oncotargets and Therapy, 2018 - europepmc.org
Methods We performed a meta-analysis of published articles on the utility of baseline NLR in
predicting outcomes in patients treated with immune checkpoint inhibitors (ICIs) using …
predicting outcomes in patients treated with immune checkpoint inhibitors (ICIs) using …
Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis
DB Sacdalan, JA Lucero, DL Sacdalan - OncoTargets and Therapy, 2018 - dovepress.com
Methods: We performed a meta-analysis of published articles on the utility of baseline NLR
in predicting outcomes in patients treated with immune checkpoint inhibitors (ICIs) using …
in predicting outcomes in patients treated with immune checkpoint inhibitors (ICIs) using …
[PDF][PDF] Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis
DB Sacdalan - OncoTargets and Therapy, 2018 - pdfs.semanticscholar.org
Introduction: Systemic inflammation is associated with prognosis in solid tumors. The
neutrophil-to-lymphocyte ratio (NLR) is a marker for the general immune response to various …
neutrophil-to-lymphocyte ratio (NLR) is a marker for the general immune response to various …
[PDF][PDF] Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis
DB Sacdalan - OncoTargets and Therapy, 2018 - scienceopen.com
Introduction: Systemic inflammation is associated with prognosis in solid tumors. The
neutrophil-to-lymphocyte ratio (NLR) is a marker for the general immune response to various …
neutrophil-to-lymphocyte ratio (NLR) is a marker for the general immune response to various …
Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis
DB Sacdalan, JA Lucero… - OncoTargets and …, 2018 - pubmed.ncbi.nlm.nih.gov
Introduction Systemic inflammation is associated with prognosis in solid tumors. The
neutrophil-to-lymphocyte ratio (NLR) is a marker for the general immune response to various …
neutrophil-to-lymphocyte ratio (NLR) is a marker for the general immune response to various …
Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis
DB Sacdalan, JA Lucero… - OncoTargets and …, 2018 - search.proquest.com
Introduction: Systemic inflammation is associated with prognosis in solid tumors. The
neutrophil-to-lymphocyte ratio (NLR) is a marker for the general immune response to various …
neutrophil-to-lymphocyte ratio (NLR) is a marker for the general immune response to various …